Richmond Pharmacology and Trial4Us were referenced in a recent Guardian article titled: Clinical trials: how taking the pills may pay those bills.

The focus is on how clinical research organisations, such as Richmond Pharmacology, are encouraging volunteers to participate in crucial early phase clinical research and how their experience is tailored to ensure they are as comfortable as possible during the process. For example, providing access to super fast broadband to enable volunteers to continue to work from the unit, stream entertainment or access in-house entertainment such as Netflix, games and reading materials. We also have a concierge service to help with transport and accommodation options. The article also contains important safety and regulatory assurances for members of the public.

Richmond Pharmacology are sector leaders in the conduct of clinical trials in both healthy and patient populations. This is demonstrated though excellent feedback and high retention rates which are essential in the safe delivery of clinical studies.

Reflections from our recent trial participants are available to view here.

Latest news

Single-dose gene silencing cure for fatal heart disease comes one step closer

March 20, 2024
Richmond is delighted to be part of the first large-scale in-human trial of a genetic cure for ATTR Amyloidosis
Read more

How Does Social Time Contribute to a Positive Workplace Culture?

March 13, 2023
Read the blog by Richmond Pharmacology’s Chair of the Social Committee and Head of Marketing, Elizabeth Romano about how being social improves organisational culture and embeds the core values.
Read more

Events

ISA Symposium 2024

29-30 May 2024 
We will be attending the XIX International Symposium on Amyloidosis, taking place in Rochester, Minesota
View event